Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
First Intervention	STARTED	Diazoxide, Then Placebo	4
First Intervention	STARTED	Placebo, Then Diazoxide	2
First Intervention	COMPLETED	Diazoxide, Then Placebo	1
First Intervention	COMPLETED	Placebo, Then Diazoxide	2
First Intervention	NOT COMPLETED	Diazoxide, Then Placebo	3
First Intervention	NOT COMPLETED	Placebo, Then Diazoxide	0
Second Intervention	STARTED	Diazoxide, Then Placebo	1
Second Intervention	STARTED	Placebo, Then Diazoxide	2
Second Intervention	COMPLETED	Diazoxide, Then Placebo	1
Second Intervention	COMPLETED	Placebo, Then Diazoxide	0
Second Intervention	NOT COMPLETED	Diazoxide, Then Placebo	0
Second Intervention	NOT COMPLETED	Placebo, Then Diazoxide	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02049385/flow